ASX Share rice
Mon 17 May 2021 - 10:02:am (Sydney)

1AD Share Price

ADALTA LIMITED1ADPharmaceuticals, Biotechnology & Life Sciences

1AD Company Information


AdAlta Limited





GIC Industry:


GIC Sub Industry:



2 Park Drive Bundoora VIC Australia 3083


61 3 9479 5159

CEO, MD & Director:

Dr. Timothy Charles Oldham B.Sc., L.L.B., BSc(Hons), LLB(Hons), Ph.D.

Chief Operating Officer:

Dr. Dallas Hartman

Chief Scientific Advisor & Chief Scientific Officer:

Prof. Michael Foley Ph.D.

Company Sec.:

Mr. Cameron Jones C.A.

Company Overview:

AdAlta Limited, a clinical stage biotechnology company, discovers and develops protein therapeutics in Australia. The company's lead i-body drug candidate includes AD-214, which is in Phase I clinical trials for the treatment of idiopathic pulmonary fibrosis and other fibrotic diseases. It has a collaborative partnership with GE Healthcare to discover i-bodies against granzyme B for use as a molecular imaging agent. AdAlta Limited was incorporated in 2006 and is based in Bundoora, Australia.

1AD Share Price Information

Shares Issued:


Market Capitalisation:


Revenue (TTM):


Revenue Per Share (TTM):


Earnings per Share:


Profit Margin:


Operating Margin (TTM):


Return On Assets (TTM):


Return On Equity (TTM):


Quarterly Revenue Growth (YOY):


Gross Profit(TTM):


Diluted Earnings Per Share (TTM):


1AD CashFlow Statement

CashFlow Date:




Change To Liabilities:


Total Cashflow From Investing Activities:


Net Borrowings:


Net Income:


Total Cash From Operating Activities:




Change To Account Receivables:


Sale Purchase Of Stock:


Capital Expenditures:


1AD Income Statement

Income Date:


Income Before Tax:


Net Income:


Gross Profit:


Operating Income:


Other Operating Expenses:


Interest Expense:


Total Revenue:


Cost Of Revenue:


1AD Balance Sheet

Balance Sheet Date:


Total Liabilities:


Total Stockholder Equity:


Other Current Liabilities:


Total Assets:


Common Stock:


Retained Earnings:


Other Liabilities:


Other Assets:




Total Current Liabilities:


Short-Term Debt:


Property - Plant & Equipment:


Net Tangible Assets:


Long-Term Investments:


Total Current Assets:


Net Receivables:


Short-Term Investments:


Accounts Payable:


Short-Term Investments:


Non Current Liabilities Total:


1AD Share Price History

1AD News

26 Feb, 2021
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
04 Jan, 2021
Melbourne, Australia--(Newsfile Corp. - January 4, 2021) - AdAlta Limited (ASX: 1AD), a clinical stage biopharmaceutical discovery and development company using i-body technology to address challenging drug targets is pleased to announce it is presenting at Biotech Showcase™ 2021, which is being held in a virtual format from 11-15 January 2021.Biotech Showcase is an investor and partnering conference focused on driving advances in therapeutic development by providing a sophisticated networking platform for executives and ...
17 Aug, 2020
With the business potentially at an important milestone, we thought we'd take a closer look at AdAlta Limited's...